PTCT logo PTC Therapeutics : PTCT

PTCT

Stock Data

$75.44

Change up

$1.34 (1.81%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

PTC Therapeutics Inc is a pioneering biopharmaceutical company dedicated to developing innovative medicines for people with rare disorders. With a global presence, it offers treatments for conditions like Duchenne muscular dystrophy, spinal muscular atrophy, and other rare diseases. Its product lineup includes Translarna, Emflaza, Upstaza, Tegsedi, Waylivra, and Evrysdi. The company is also advancing research in areas such as Huntington’s disease and amyotrophic lateral sclerosis through its development pipeline. Founded in 1998 and based in South Plainfield, New Jersey, PTC Therapeutics collaborates with leading healthcare organizations to enhance its reach and impact.

All PTC Therapeutics Articles

9 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.